Work Here?
Overview
Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.
About Nomic
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Get referred to Nomic
See people who can refer or advise you
Simplify's Take
What believers are saying
- Nomic raised $42 million Series B in September 2024, expanding commercial operations.
- April 2026 Broad Clinical Labs partnership expands Omni 1000 into translational workflows.
- June 2026 Wellcome Sanger collaboration adds immune-genetics datasets across 1,500 perturbed PBMC samples.
What critics are saying
- Olink and SomaScan dominate proteomics, squeezing Nomic's adoption and pricing power.
- Nomic's service-heavy model depends on converting collaborations into recurring consumables revenue.
- If Omni 1000 stalls, Nomic remains a niche service lab, not a platform company.
What makes Nomic unique
- Omni 1000 launched in 2025 delivers 1,000 proteins with absolute quantification.
- Nomic's nELISA promises high multiplexing and lower cost than traditional antibody assays.
- Broad Clinical Labs and Wellcome Sanger validated Nomic in translational and genetics workflows.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$60.1M
Above
Industry Average
Funded Over
4 Rounds
Y CombinatorIndustry standards
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 5%MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.
Y Combinator’s Demo Day was a bit different this time around.
Nomic is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Nomic
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Nomic is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today